The current status of CLL treatment and how clinical practice will change
The relationship between basic and clinical research in CML
Safety profile of anti-CD19 CAR T-cell therapy axicabtagene ciloleucel
Treatment at first relapse in multiple myeloma: how to choose a drug?
Prof. Gribben's highlights from ASH 2016